Related Experiment Video
Updated: May 1, 2026

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
Published on: December 18, 2014
Intractable vascular autonomic dysregulation (Harlequin phenomenon) in two brothers: another indication for
S R Janmohamed1, G C Madern, P C J de Laat
1Department of Pediatric Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Division of Pediatric Dermatology, Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; KinderHaven, Havenziekenhuis, Rotterdam, The Netherlands.
Abstract:
Vascular autonomic dysregulation, in the most extreme presentation known as Harlequin phenomenon, is a rare condition. It manifests as a sudden and brief paroxystic change in skin color, resulting in two different colors on the body. It is supposed that this condition occurs due to a vasomotor instability. This again is caused by sympathetic disautonomy, which is a consequence of hypothalamic peripheral vascular tone control immaturity in the newborn. Typically, there is spontaneous regression. We describe two brothers who both had this condition in their first life years. Clinical symptoms included frequent attacks of discoloration of extremities (up to four times per day) accompanied with terrifying crying fits, interpreted by the parents as pain. These patients were treated with propranolol, a nonselective beta-blocker, resulting in improvement of symptoms: only occasional attacks were seen. Beta-blockers act on β1 -adrenoceptors in the heart, thereby preventing the positive chronotropic and inotropic effects mediated by these receptors. We hypothesize that propranolol, which is very lipophilic and therefore also acts on β-receptors of the central nervous system, acts on the sympathetic system.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Heart Failure Drugs: β-Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Types of β-Blockers
Antihypertensive Drugs: Vasodilators

